Genetic Changes Influence Breast Cancer Development and Survival
Dec. 14, 1999 (Baltimore) -- Genetic changes known as mutations do influence
the development of breast cancer, the course of the disease, and survival,
reports a study in the Dec. 15 issue of the Journal of the National Cancer
Institute. However, the presence of these mutations alone, called BRCA
mutations, does not predict who will survive and should not influence therapies
a woman may receive following surgery.
"Our results may give us an opportunity to reduce the risk of women with
BRCA mutations by applying aggressive surveillance strategies," says Mark
Robson, MD, the study's lead author, in an interview with WebMD. "What
we're recommending now is breast self-exam once a month and breast exam by a
provider three or four times a year, in addition to mammography. And we're
starting surveillance at age 25, since these women begin to be at risk in their
late 20s," says Robson, who is with Memorial Sloan-Kettering Cancer Center
in New York.
The study included over 300 women of Ashkenazi Jewish descent who had a
lumpectomy for breast cancer and looked for the presence of the mutations by
DNA analysis of the lymph nodes. Other clinical data included age of the
patient at diagnosis, whether the cancer was in the lymph nodes, size of the
tumor, and appearance of the tumor under the microscope. Women of Ashkenazi
descent were selected for this study because the mutations occur more often in
this population than they do in the general population.
Results detected BRCA mutations in 28 of the women. Women with mutations
were more likely to be diagnosed with cancer before the age of 50, to have
lymph node involvement in the cancer, to experience breast tumor recurrence on
the same side as the original tumor, and to develop another tumor in the other
breast. The length of time before recurrence of breast cancer was reduced in
these women, as was their likelihood of dying from breast cancer. "Women
with mutations typically had more advanced disease at presentation
[diagnosis]," says Robson. "However, mutation status alone did not
What is the place of genetic testing in prevention of breast cancer? Roy
Smith, MD, director of medical affairs and medical oversight at the National
Surgical Adjuvant Breast and Bowel Project in Pittsburgh, answered that
question for WebMD in an interview on the paper. He says, "Right now you'll
get different opinions from different people, but what most women need to know
is whether they have a family history of breast cancer. If the answer is yes,
then you need to think about more aggressive surveillance."
Smith continues, "We're going to be hearing a lot more about mutations
that are related to breast cancer, and women who have these mutations are
getting scared. Some of them are saying, 'I have a family history of breast
cancer, we need to take this breast off,' but the more conservative view is
these women need to do regular breast self-exams and have regular mammograms.
They also need to be reassured that just because you have a family history or a
mutation, it doesn't mean you will necessarily develop breast cancer."